ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

A phase I trial of dasatinib, an SRC-family kinase inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer.

Angeles Alvarez Secord et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.